Atara Biotherapeutics (NASDAQ:ATRA – Get Free Report) and Recursion Pharmaceuticals (NASDAQ:RXRX – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, institutional ownership and valuation. Insider & Institutional Ownership 70.9% of Atara […]

Evaxion Biotech A/S (NASDAQ:EVAX – Get Free Report) and Regen BioPharma (OTCMKTS:RGBP – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, dividends, analyst recommendations and valuation. Institutional and Insider Ownership 11.0% of Evaxion […]

Agenus (NASDAQ:AGEN – Get Free Report) and Scholar Rock (NASDAQ:SRRK – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, dividends, profitability, valuation and earnings. Insider and Institutional Ownership 61.5% of Agenus shares […]

BEIJING ENTPS H/S (OTCMKTS:BJINY – Get Free Report) and Raiffeisen Bank International (OTCMKTS:RAIFY – Get Free Report) are both mid-cap utilities companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends. Dividends BEIJING ENTPS H/S pays […]

BTCS (NASDAQ:BTCS – Get Free Report) and X Financial (NYSE:XYF – Get Free Report) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, valuation and risk. Insider & Institutional Ownership 3.5% of BTCS shares […]

StockNews.com began coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a research note published on Tuesday. The firm issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Price Performance The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.24. Genocea Biosciences […]

Investment analysts at StockNews.com started coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Get Free Report) in a report issued on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Nabriva Therapeutics Price Performance Shares of Nabriva Therapeutics stock opened at $0.00 on Wednesday. The firm has a market capitalization of $6,403.00, […]